Back to search

Article

Biomarkers for the Management of Cholangiocarcinoma: Unveiling New Horizons for Precision Therapy

2025-01-23

Abstract excerpt

Cholangiocarcinoma (CCA) is an aggressive malignancy with limited methods for early detection, necessitating the development of reliable biomarkers for diagnosis and management. However, conventional tumor markers, such as CA19-9 and CEA, exhibit insufficient diagnostic accuracy. Recent advancements in molecular genetics have identified several actionable mutations in CCA, enabling molecularly targeted therapies t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a2cdc8c4-f233-52c5-92b6-5ed9cac047ea
DOI
10.20944/preprints202501.1720.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biomarkers for the Management of Cholangiocarcinoma: Unveiling New Horizons for Precision TherapyDOI 10.20944/preprints202501.1720.v1
Select a neighboring publication to make it the new centre.